Search PubMed⌕ Search

Biomedical subjects

D Morel

Publications and source records attributed to D Morel.

At least 73 records · Page 4Linked to original sources
PubMed1989

Effect of a ketoacid diet on glucose tolerance and tissue insulin sensitivity.

Effects of a low protein (0.3 g/kg/day) diet on glucose tolerance and tissue insulin sensitivity were studied in 25 non-diabetic and eight insulin-dependent diabetic uremic patients before and three months after dietary treatment. Carbohydrates accounted for 65% of the caloric intake in the first group and 57% in the second. In the first group, a 50 g oral glucose tolerance test showed that after three months blood glucose was significantly reduced at T60 (P less than 0.05) and serum insulin at T0, T30 (P less than 0.05) and T60 (P less than 0.02). Ten patients of the first group underwent an euglycemic, hyperinsulinemic clamp study; the tissue sensitivity to insulin index of all three clamp periods improved (P less than 0.01 for the first and second, P less than 0.02 for the third). Five patients in the second group underwent a euglycemic clamp study; glucose metabolism increased with each clamp period. Concomitantly, their daily insulin requirements decreased from 37.2 +/- 3.1 to 24.8 +/- 2.7 U/day (P less than 0.05). This conspicuous improvement observed in both groups might be related to a decrease in uremic toxin(s) derived from protein intake. Beneficial results on atherosclerosis and cardiovascular pathology may occur from the reduction of hyperinsulinism.

Adult↗
PubMed1989

[Castleman's disease and glomerular nephropathy (apropos of 1 case].

We report a case of Castleman's disease of multifocal plasma-cell type revealed by a severe general weakness, associated to a nephrotic syndrome with renal failure. The characteristic aspects of lymphoid hyperplasia with hyalinization of follicles and interfollicular vascular proliferation were observed in mesenteric lymph nodes, the spleen was involved by an infarcted localisation of Castleman's disease. The glomerular lesions were consistent with a proliferative mesangial glomerulonephritis. The removal of the spleen and of the mesenteric nodes involved by the disease, associated with a steroid course was curative. The nephrotic syndrome appears to be etiologically related to the presence of the Castleman's tumor. The removal of the tumor relieves the proteinuria and the renal failure as in other cases reported in the literature.

Acute Kidney Injury↗
PubMed1988

[Low-dose midazolam. Effect on the induction doses of fentanyl and on hemodynamics in the coronary patient].

A study was carried out to see whether the administration of a small dose of midazolam determined a reduction of the dose of fentanyl necessary for induction of anaesthesia. Sixteen patients undergoing coronary artery bypass surgery were randomly allocated to either of two groups. Patients in group M received 0.075 mg.kg-1 midazolam intravenously 3 to 5 min prior to induction with fentanyl (5 micrograms.kg-1.min-1), whereas patients in group P only received placebo. The mean dose of fentanyl administered to obtain complete loss of reaction to a painful stimulus was 20 +/- 3 micrograms.kg-1 in group M and 21.5 +/- 2.5 micrograms.kg-1 in group P (NS). However the small dose of midazolam associated with fentanyl caused a significant drop in blood pressure by 20%. After the administration of pancuronium (0.15 mg.kg-1), the patients in group P showed a significant increase in heart rate (+ 14 b.min-1), accompanied by an increase in cardiac index (+0.45 l.min-1.m-2). Pretreatment with midazolam seemed to protect the patient from this undesirable reaction. It was concluded that induction with a combination of a small dose of midazolam and fentanyl did not lead to a reduction in the dose of fentanyl necessary to obtain profound analgesia. However, it gave rise to a haemodynamic pattern quite distinct from that seen during induction with fentanyl alone.

Anesthesia, General↗
PubMed1988

Effect of a low-protein diet on chemiluminescence production by leukocytes from uremic patients.

Chemiluminescence (CL) emission from leukocytes was studied in 20 uremic patients after ingestion of opsonized zymosan. CL production was impaired when compared with control groups. Six months after a low-protein, low-phosphorus diet supplemented with essential amino acids and ketoanalogues (SD) was started, a significant improvement in CL production was observed. SD may be expected to decrease the susceptibility of uremic patients to bacterial infections.

Adult↗
PubMed1988

Effect of a low-protein diet on urinary albumin excretion in uremic patients.

Fifteen patients with advanced renal failure (creatinine clearance less than 25 ml/mn) and with severe albuminuria (greater than 1.5 g/24 h) were put on a low-protein (0.3 g/kg body weight), low-phosphorus (5-7 mg/kg body weight) diet supplemented with essential amino acids and ketoanalogues. During the 6-month follow-up, urinary albumin excretion and fractional renal albumin clearance were reduced significantly while serum albumin concentration increased; no nutritional change occurred during the study.

Adult↗
PubMed1986

Intra-cytoplasmic crystalline inclusions in acute myeloid leukemia: a rare event.

Unusual intracytoplasmic crystal-like inclusions within granulocytic precursor cells from a patient with acute myeloid leukemia (AML) are described. Based upon their cytochemical and immunochemical properties, the possible composition and origin of these inclusions are discussed. They represent a rare event in leukemic cell metabolism since, to our knowledge, only 1 case with identical characteristics has previously been reported.

Aged↗
PubMed1984

Effects of infrarenal aortic cross-clamping on renal hemodynamics in humans.

While the systemic cardiovascular consequences of infrarenal aortic cross-clamping during aortic abdominal surgery are well documented, its repercussions on renal hemodynamics in humans have not been reported. In 12 patients, scheduled for elective aortic surgery, renal clearances, using 51Cr EDTA and 125I hippuran, were measured before, during, and after infrarenal aortic cross-clamping. A continuous infusion of mannitol 20% at a rate of 100 ml/h was administered throughout the study. Arterial and renal venous blood sampling, obtained at the midpoint of each period, permitted calculation of the extraction fraction of 125I hippuran and accurate determination of renal blood flow and its cortical-extracortical distribution. Although cardiac output and systemic vascular resistance did not change significantly between the three study periods, infrarenal aortic cross-clamping decreased 125I hippuran clearance by 29 +/- 15% (P less than 0.05) and renal blood flow by 38 +/- 14% (P less than 0.001). Simultaneously, an increase of 75 +/- 31% in renal vascular resistance (P less than 0.05) was observed and the extraction fraction of 125I hippuran increased from 0.67 +/- 0.05 to 0.74 +/- 0.05 (P less than 0.01). All of these changes, which indicate global diminution of renal perfusion with a redistribution of renal blood flow toward the cortical compartment, persisted for at least 1 h after release of the aortic clamp. Early signs of renal tubular damage, such as the appearance of lysozyme and ligandine in the urine, however, were never observed. The authors conclude that infrarenal aortic cross-clamping produces profound and sustained alterations in renal hemodynamics and may be harmful in patients with impaired renal function or when surgical occlusion of the aorta is prolonged.

Aged↗
PubMed1983

[Longterm psychosis and sultopride].

The action of sultopride was studied in patients with chronic psychosis during rehospitalization for a psychopathic episode. 22 patients (8 manic-depressive psychoses and 14 schizophrenias) were given sultopride as the sole therapy, in a daily dose of 4 vials. After symptomatic improvement therapy was continued by the oral route. Under these conditions, a satisfactory response was recorded in 81.8% of patients. These results are confronted with those previously obtained in a comparable group of patients given phenothazines. A statistically significant difference was found, with sultopride being more effective and acting more rapidly than phenothiazines.

Adult↗
PubMed1983

Effects of midazolam on cerebral hemodynamics and cerebral vasomotor responsiveness to carbon dioxide.

Although it is known that hypercarbia increases and benzodiazepines decrease cerebral blood flow (CBF), the effects of benzodiazepines on CBF responsiveness to CO2 are not well documented. The influence on CBF and CBF-CO2 sensitivity of placebo or midazolam, which is a new water-soluble benzodiazepine, was measured in eight healthy volunteers using the noninvasive 133Xe inhalation method for CBF determination. Under normocarbia, midazolam decreased CBF from 40.6 +/- 3.2 to 27.0 +/- 5.0 ml 100 g-1 min-1 (means +/- SD). At a later session under hypercarbia, CBF was 58.8 +/- 4.4 ml 100 g-1 min-1 after administration of placebo, and 49.1 +/- 10.2 ml 100 g-1 min-1 after midazolam. The mean of the slopes correlating PaCO2 and CBF was significantly steeper with midazolam (2.5 +/- 1.2 ml 100 g-1 min-1 mm Hg-1) than with placebo (1.5 +/- 0.4 ml 100 g-1 min-1 mm Hg-1). Our results suggest that midazolam may be a safe agent to use in patients with intracranial hypertension, since it decreases CBF and thus cerebral blood volume; however, it should be administered with caution in nonventilated patients with increased intracranial pressure, since its beneficial effects on cerebrovascular tone can be readily counteracted by the increase in arterial CO2 tension induced by this drug.

Adult↗
PubMed1983

Respiratory depressant effects of different doses of midazolam and lack of reversal with naloxone--a double-blind randomized study.

Conflicting data concerning the ventilatory effects of benzodiazepines may be caused by the large variability in investigational conditions. Respiratory effects of three different intravenous doses of midazolam (0.05 mg/kg, 0.1 mg/kg, 0.2 mg/kg) and placebo were measured in a double-blind and randomized fashion in eight healthy volunteers. The respiratory variables were analyzed by means of a noninvasive method, thereby avoiding interferences associated with the stimulating effects of mouthpiece and nose clip. After injection of midazolam, tidal volume decreased by 40% with the three doses and respiratory frequency increased to the same extent, minute ventilation remained constant. Only the largest dose of the drug produced a significant decrease (P less than 0.05) in O2 saturation that was related to the longer duration of apnea. Intravenous naloxone (0.015 mg/kg) injected 5 min after midazolam did not change any measured respiratory or hemodynamic variable. We conclude that the respiratory effects of midazolam are poorly dose related and not reversed by naloxone. The observed compensatory increase in respiratory frequency which is not noted in other studies, is probably related to the noninvasive measurement technique used.

Adult↗
PubMed1982

[Monitoring of respiration and respiratory mechanics in intensive care].

Monitoring of respiratory function in the intensive care unit uses different techniques in spontaneously breathing patients and during mechanical ventilation. The simplest and most efficient means are clinical observation, non-invasive monitoring of respiratory movements and frequent blood gas analysis. The respiratory force and reserves can be assessed by measuring tidal volume, vital capacity and maximal inspiratory force (in cm H2O or mm Hg), and these values are helpful in deciding on ventilatory assistance or extubation. During mechanical ventilation the function of the respirator must be monitored by appropriate sensors and alarms. In addition, the measurement of functional residual capacity, compliance and distribution of ventilation, as well as changes therein with the application of positive end-expiratory pressure (PEEP), can contribute to evaluate of appropriate therapy and prognosis of pulmonary failure.

Blood Gas Analysis↗
PubMed1982

[Influence of cimetidine on bacterial growth in gastric fluid (author's transl)].

Samples of gastric fluid were tested for pH and number of bacteria in 20 patients who received cimetidine 400 mg prior to selective gastric surgery. The results were compared with those obtained in a group of surgical patients who did not receive the drug. The cimetidine-treated patients had alkaline gastric fluid with pronounced bacterial growth (4.7 +/- 0.6 x 10(4) micro-organisms/ml), whereas 18/20 untreated patients has a sterile gastric fluid. Similar results were observed in 14 intensive care patients treated for 24 hours with cimetidine. The effect proved reversible: 12 hours after treatment was discontinued bacterial growth could only be demonstrated in 3/14 patients. Thus, short-term cimetidine treatment results in a rise of gastric pH with marked bacterial proliferation. This may have serious consequences in cimetidine-treated patients about to undergo gastric surgery or likely to develop aspiration pneumonia.

Bacteria↗
PubMed1982

Evaluation of a new monitoring device for arterial blood pressure and heart rate measurement by automatic sphygmomanometry.

Measurements of arterial blood pressure (BP) and heart rate (HR) using a new non-invasive automatic apparatus were compared with the BP and HR values obtained with an invasive technique, i.e. arterial catheter and pressure transducer. This new device consists of a self-inflating BP cuff and of a microphone which converts Korotkoff sounds into digital values. The comparison was made on 400 measurements in 10 surgical intensive-care patients during 18 hours after open heart surgery. Systolic pressure was underestimated by the new device by 13 +/- 20 mm Hg/1.7 +/- 2.6 kPa (means +/- SD) and the linear correlation coefficient between the non-invasive and the invasive technique was r = 0.70. Diastolic pressure was overestimated by 9.4 +/- 12.0 mmHg (1.2 +/- 1.5 kPa) with an r = 0.63. HR was also underestimated by 7 +/- 17 heart beats per minute (r = 0.58). We conclude that this new device is not adequate for monitoring intensive-care patients, not so much because of the differences noted between the invasive and the non-invasive measurements, but in particular because there are no alarms, no mean arterial pressure measurement and also because it gives aberrant results once out of twenty measurements.

Anesthesia, General↗
PubMed1982

Effects of midazolam on cerebral blood flow in human volunteers.

The effects of intravenously administered midazolam on cerebral blood flow were evaluated in eight healthy volunteers using the 133Xe inhalation technique. Six minutes after an intravenous dose of 0.15 mg/kg midazolam, the cerebral blood flow decreased significantly (P less than 0.001) from a value of 40.6 +/- 3.3 to a value of 27.0 +/- 5.0 ml . 100 g-1 . min-1. Cerebrovascular resistance (CVR) increased from 2.8 +/- 0.2 to 3.9 to 0.6 mmHg/(ml . 100 g-1 . min-1)(P less than 0.001). Mean arterial blood pressure decreased significantly (P less than 0.05) from 117 +/- 8 to 109 +/- 9 mmHg and arterial carbon dioxide tension increased from 33.9 +/- 2.3 to 38.6 +/- 3.2 mmHg (P less than 0.05). Arterial oxygen tension remained stable throughout the study, 484 +/- 95 mmHg before the administration of midazolam and 453 +/- 76 mmHg after. All the subjects slept after the injection of the drug and had anterograde amnesia of 24.5 +/- 5 min. The decrease in mean arterial blood pressure was probably not important since it remained in the physiologic range for cerebral blood flow autoregulation. The increase in arterial carbon dioxide tension observed after the midazolam injection may have partially counteracted the effect of this new benzodiazepine on cerebral blood flow. Our data suggest that midazolam might be a safe agent to use for the induction of anethesia in neurosurgical patients with intracranial hypertension.

Adult↗